Charles Swanton
From Wikipedia, the free encyclopedia
EMBO Member (2017)
Charles Swanton | |
|---|---|
 Swanton in 2018 | |
| Born | Robert Charles Swanton 1972 (age 53–54)[1] |
| Education | St Paul's School, London |
| Alma mater | University College London (MD, PhD) |
| Awards | Ellison–Cliffe Lecture (2017) EMBO Member (2017) |
| Scientific career | |
| Fields | Cancer evolution[2] |
| Institutions | Francis Crick Institute University College London |
| Thesis | Viral cyclin disruption of mammalian cell cycle control mechanisms (1998) |
| Doctoral advisor | Nic Jones |
| Website | www |
Robert Charles Swanton is a British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute,[3] Royal Society Napier Professor in Cancer[4] and thoracic medical oncologist at University College London[5] and University College London Hospitals,[6][7] co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.[8][9]
Swanton was born in Poole, Dorset. As of 2017, his father Robert Howard Swanton (MD, FRCP) was a consultant cardiologist at UCL.[10]
Swanton was educated at St Paul's School, London[1] and completed his PhD in 1999[11] at what was then the Imperial Cancer Research Fund Laboratories (now the Francis Crick Institute) and his Cancer Research UK clinician scientist/medical oncology training in 2008.[7]
![[icon]](#/media/File:Wiki_letter_w_cropped.svg){kind=small}
